Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Stocks
Currencies
Cryptocurrencies
Metals
Indices
Commodities
ETFs
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
News
Top Providers News
Top Providers News
Symbols
Market
Provider
Time
Symbols
News
Provider
2026.11.12
Applied Materials Reports Q4 Earnings, Raises Guidance as AI Drives Strong Chip Demand (CORRECTED)
Benzinga
2026.11.12
AnaptysBio Q3 EPS $0.11 Misses $ 0.51 Estimate, Sales $30.274M Miss $33.186M Estimate
Benzinga
2026.11.12
US Antimony Shares Sink on Disappointing Q3 Print, Pulled Guidance
Benzinga
2026.11.12
Electra Therapeutics Q3 EPS $(3.47) Misses $(2.72) Estimate
Benzinga
2026.11.12
Polaryx Therapeutics Q3 EPS $(0.07) Misses $(0.04) Estimate
Benzinga
2026.11.12
CORRECTION: Applied Mat Q4 Adj. EPS $4.16 Beats $4.05 Estimate, Sales $10.410B Beat $10.299B Estimate
Benzinga
2026.11.12
Vylor Files Shelf Prospectus For Offering; Size Not Disclosed
Benzinga
2026.11.12
4D Molecular Therapeutics Q3 EPS $(1.08) Misses $(1.05) Estimate, Sales $4.100M Beat $2.700M Estimate
Benzinga
2026.11.12
SmartStop Self Storage REIT Enters Forward Sale Agreements Relating To 8.15M Shares At $35.6125/Share
Benzinga
2026.11.12
Obsidian Therapeutics Q3 EPS $(1.23) Up From $(14.77) YoY
Benzinga
2026.11.12
Immix Biopharma Q3 EPS $(0.19), Inline
Benzinga
2026.11.12
Sidus Space Says Q3 2024 And Q1 Through Q3 2025 Financial Statements Also Should Not Be Relied Upon, Expanding Restatement Scope
Benzinga
2026.11.12
CaliberCos Lowers FY2026 Sales Guidance from $18.000M-$22.000M to $15.000M-$17.000M vs $0.00 Est
Benzinga
2026.11.12
Spero Therapeutics Q3 EPS $(0.76) Misses $(0.47) Estimate
Benzinga
2026.11.12
Ensysce Biosciences Q3 Adj. EPS $(0.13) Misses $(0.12) Estimate, Sales $2.182M Beat $1.200M Estimate
Benzinga
2026.11.12
If You Invested $1000 In UnitedHealth Group Stock 20 Years Ago, You Would Have This Much Today
Benzinga
2026.11.12
Gaxos.AI Q3 EPS $(0.08) Beats $(0.11) Estimate, Sales $2.810M Miss $3.000M Estimate
Benzinga
2026.11.12
AIM ImmunoTech Q3 EPS $(0.21) Misses $(0.14) Estimate, Sales $22.000K Down From $26.000K YoY
Benzinga
2026.11.12
NET Power Q3 EPS $(0.07) Misses $(0.05) Estimate
Benzinga
2026.11.12
Sanara MedTech Q3 EPS $0.15 Beats $0.08 Estimate, Sales $28.400M Miss $29.667M Estimate
Benzinga
2026.11.12
Nu Holdings Reports Strong Q3: EPS in Line, Revenue Above Estimates
Benzinga
2026.11.12
Liquidmetal Technologies Q3 Sales $225.000K Up From $37.000K YoY
Benzinga
2026.11.12
Sutro Biopharma Q3 EPS $(1.90) Beats $(1.91) Estimate, Sales $9.100M Miss $10.342M Estimate
Benzinga
2026.11.12
AuthID Q3 EPS $(0.24) Up From $(0.38) YoY, Sales $260.000K Down From $596.337K YoY
Benzinga
2026.11.12
Evommune Q3 EPS $(0.85) Misses $(0.84) Estimate
Benzinga
2026.11.12
Hour Loop Q3 EPS $0.01, Same YoY, Sales $32.100M Down From $33.425M YoY
Benzinga
2026.11.12
Battalion Oil Q3 Adj. EPS $(0.75) Up From $(0.96) YoY, Sales $45.600M Up From $43.482M YoY
Benzinga
2026.11.12
SoundThinking Q3 EPS $(0.64) Misses $(0.17) Estimate, Sales $25.000M Miss $25.023M Estimate
Benzinga
2026.11.12
Eledon Pharma Q3 Adj. EPS $(0.16) Beats $(0.19) Estimate
Benzinga
2026.11.12
East Side Games Group Q3 Sales $10.791M Down From $20.053M YoY
Benzinga
1
...
45
46
47
48
49
50
...
712
>